Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery

Summary

Rivaroxaban versus enoxaparin for prophylaxis of venous thromboembolism in morbidly obese patients undergoing bariatric surgery: An open\_label randomized controlled trial

Timeline

Start

2024-10-01

Primary completion

2025-12-01

Completion

2026-05-01

Publications

• Background Wagner J, Wruck H, Lautenbach A, von Kroge P, Wolter S, Mann O, Izbicki J, Dupree A. Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis. Obes Surg. 2022 Mar;32(3):861-867. doi: 10.1007/s11695-021-05875-z. Epub 2022 Jan 5.

Drugs

Indications